Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Dr Phaedra Corso Discusses How to Incorporate Economic Research Into Health Policy
May 8th 2024Phaedra Corso, PhD, associate vice president for research, Indiana University, discusses the importance of cost-effectiveness analysis in determining the feasibility and impact of public health interventions.
Watch
How the IRA May Shift Economic Incentives for Drug Manufacturers: Dr Julie Patterson
May 8th 2024The Inflation Reduction Act (IRA) has potential to shift incentives for drug manufacturers and impact the amount of long-term evidence generated for approved drugs, said Julie Patterson, PharmD, PhD, senior director of research at the National Pharmaceutical Council.
Watch
Dr William Padula Explores Applications of Cost-Effectiveness Analysis in Health Care
May 8th 2024William Padula, PhD, MSc, MS, assistant professor of pharmaceutical and health economics, University of California Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, discusses the benefits and advancements of cost-effectiveness analysis to improve decision-making and efficiency.
Watch
Dr Angela Jia Outlines Decisions on Treatment or Observation in Prostate Cancer
May 7th 2024Risk factors and prostate-specific antigen are both important when determining how to move forward with treatment, explained Angela Jia, MD, PhD, of University Hospitals and Case Western Reserve University School of Medicine.
Watch
Recent Advancements Have Disrupted the Field of Bladder Cancer, Says Dr Alexander Kutikov
May 7th 2024There are increasingly more bladder-sparing strategies for patients with even aggressive bladder cancer, said Alexander Kutikov, MD, FACS, chair, Department of Urology, Fox Chase Cancer Center.
Watch
Mary Dunn: We’ve Come a Long Way in Treatment for Urologic Cancers
May 6th 2024With more therapies available in bladder, kidney, and prostate cancers, collaboration among health care providers can help ensure patients are getting the most appropriate care for their type and stage of cancer, said Mary Dunn, MSN, NP-C, OCN, RN, of University of North Carolina.
Watch
Dr Seth Berkowitz on Whole-Person Health Indexes, the "Wrong Pocket" Problem
May 6th 2024Seth Berkowitz, MD, MPH, associate professor of medicine, University of North Carolina at Chapel Hill, discussed the challenges associated with developing a whole-person health index and potential solutions for the "wrong pocket" problem.
Watch
Dr Binod Dhakal: The Importance of Patient Monitoring With Cilta-Cel Treatment
May 6th 2024In part 2 of our interview with Binod Dhakal, MD, he addresses how CARTITUDE-4 study findings help to advance the clinical understanding of ciltacabtagene autoleucel (cilta-cel) and the importance of vigilance and education on the treatment’s adverse effects.
Watch
Dr Joshua Meeks on the Benefits, Challenges of Many Options to Treat Bladder Cancer
May 6th 2024There are many options to try for patients if one therapy doesn’t work, but there are challenges around getting new treatments into the clinic, said Joshua Meeks, MD, PhD, of Northwestern University Feinberg School of Medicine.
Watch
Identifying Good Candidates for Active Surveillance of Kidney Cancer
May 5th 2024Patients with small or slow-growing tumors or those with comorbidities that make them higher risk are likely better candidates for active surveillance, explained Yuzhi Wang, MD, of Henry Ford Health Vattikuti Urology Institute.
Watch
Advancements in Bladder Cancer Treatment Require Multidisciplinary Team Care
May 5th 2024Evolving treatment for bladder cancer is going to require a multidisciplinary team to ensure patients are receiving optimal care, said Neal D. Shore, MD, FACS, medical director of the Carolina Urologic Research Center.
Watch
Dr Chesahna Kindred Discusses the Strengths of Diversity in Psoriasis Clinical Trials
May 3rd 2024Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Center, discusses how to accurately represent findings from diverse populations and translate them into clinical practice.
Watch
Dr Darius Lakdawalla Previews the ISPOR 2024 Conference
May 3rd 2024Darius Lakdawalla, PhD, director of research, Schaeffer Center for Health Policy & Economics at the University of Southern California, discusses the growing importance of value assessment in the US market, highlighting research gaps and the need for equitable access to prescription drugs, as a presenter at the ISPOR 2024 conference.
Watch
Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease
May 1st 2024Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.
Read More
Health-System Specialty Pharmacies Reduce the Chances of Dropping the Ball, Says Dr Ryan Nix
May 1st 2024The health-system specialty pharmacy has the unique ability to coordinate better with the provider and take a team approach that reduces the chances of dropping the ball on the patient’s care.
Watch
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More
Preferred Positioning of Biosimilars a Powerful Lever for Adoption, Says Dr Fran Gregory
May 1st 2024There are multiple levers that need to be pulled to allow biosimilars to come to market more broadly in the US, explained Fran Gregory, PharmD, MBA, vice president of emerging therapies, Cardinal Health.
Watch